Treating HER2 Lung Cancers: The EUHER2 CohortTreating HER2 Lung Cancers: The EUHER2 Cohort

Is trastuzumab beneficial in combination with chemotherapy for advanced HER2-positive advanced NSCLC? Annals of Oncology

Source: Medscape Pathology Headlines - February 26, 2016 Category: Pathology Tags: Hematology-Oncology Journal Article Source Type: news